{"id":61648,"date":"2025-07-28T16:03:52","date_gmt":"2025-07-28T14:03:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/"},"modified":"2025-07-28T16:03:52","modified_gmt":"2025-07-28T14:03:52","slug":"ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/","title":{"rendered":"TA Invests in HealthMark Group to Support the Next Phase of Growth"},"content":{"rendered":"
\n

DALLAS–(BUSINESS WIRE)–HealthMark Group (\u201cHealthMark\u201d or \u201cthe Company\u201d), a leading provider of clinical information exchange solutions for healthcare providers, today announced a strategic growth investment from TA Associates (\u201cTA\u201d), a leading global private equity firm. This partnership aims to accelerate HealthMark\u2019s growth as the Company advances its mission to optimize the exchange of healthcare data through cutting-edge technology.<\/p>\n

<\/a>
<\/a><\/p>\n

\nAs part of the transaction, HealthMark management and existing investor Ridgemont Equity Partners will both roll meaningful ownership stakes, welcoming TA as the new lead investor. Financial terms of the transaction were not disclosed.<\/p>\n

\n“TA\u2019s belief in our vision has been evident for years, as they\u2019ve closely followed our progress and laid the groundwork for this collaboration,\u201d said Bart Howe, CEO of HealthMark.<\/b> \u201cWith deep expertise in scaling healthcare technology businesses, their partnership, along with the continued support from Ridgemont, marks a pivotal moment for our company, positioning us to expand our capabilities and broaden our market reach. Together, we will continue transforming the patient information journey by driving efficiency, interoperability, and compliance to increase quality of care across the healthcare industry.”<\/p>\n

\nFounded in 2006, HealthMark\u2019s platform enables healthcare providers to outsource clinical information requests from health plans, law firms, insurance companies, patients, and other requestors. Through a network of over 60,000 providers and 5,000 facilities nationwide, the Company integrates with a disparate set of data sources and over 100 electronic medical record systems, allowing clinical information to be exchanged on an ongoing basis to meet compliance requirements. To date, HealthMark has processed more than 20 million clinical data requests, helping thousands of hospitals and clinics transform manual administrative processes into seamless digital encounters.<\/p>\n

\n“HealthMark\u2019s technology offers a compelling value proposition for providers and requestors alike,\u201d said Ethan Liebermann<\/b>, Managing Director and Head of the North America Healthcare Group at TA<\/b>. \u201cBy streamlining clinical information exchange, requestors benefit from lower costs and faster access to fragmented clinical data. At the same time, providers gain meaningful administrative efficiencies, reduced compliance risk, and stronger patient satisfaction. We are proud to support HealthMark\u2019s mission to further automate a mission-critical healthcare information workflow and ultimately drive better outcomes for patients across the healthcare ecosystem.”<\/p>\n

\n\u201cWe have spent considerable time assessing the broader healthcare interoperability landscape, focusing on scalable solutions that solve the complexities of structuring and exchanging fragmented healthcare data,\u201d added Eric Zagorski, Senior Vice President at TA<\/b>. \u201cWe\u2019re thrilled to partner with Bart, Ridgemont, and the exceptional HealthMark team as they continue to lead innovation in this critical area of healthcare infrastructure.\u201d<\/p>\n

\n\u201cSince our investment, HealthMark\u2019s footprint has expanded from three to 49 states, and its technological capabilities have advanced significantly,\u201d said Anthony Cassano<\/b>, Partner at Ridgemont Equity Partners<\/b>. \u201cWe\u2019re immensely proud of our partnership with Bart and the entire management team, and by partnering with TA, we\u2019re even more excited to deepen interoperability, unlock new efficiencies for providers, and elevate patient care in the years ahead.\u201d<\/p>\n

\nAbout HealthMark Group
\n
<\/b>HealthMark Group is a leading provider of clinical information exchange solutions for healthcare providers across the country. With an unrelenting focus on the patient experience, HealthMark delivers secure, compliant, and technology-driven solutions to streamline the patient information journey. Our health data exchange solution helps thousands of hospitals and clinics transform administrative processes into seamless digital encounters. HealthMark Group is based in Dallas, TX and has been named to both the Dallas 100 and the Inc. 5000 for multiple years in a row as one of the fastest growing companies in the region and across the country. To learn more, visit us at healthmark-group.com<\/a> or follow us on LinkedIn<\/a>.<\/p>\n

\nAbout TA
\n
<\/b>TA is a leading global private equity firm focused on scaling growth in profitable companies. Since 1968, TA has invested in more than 560 companies across its five target industries – technology, healthcare, financial services, consumer and business services. Leveraging its deep industry expertise and strategic resources, TA collaborates with management teams worldwide to help high-quality companies deliver lasting value. The firm has raised $65 billion in capital to date and has more than 150 investment professionals across offices in Boston, Menlo Park, Austin, London, Mumbai and Hong Kong. More information about TA can be found at www.ta.com<\/a>.<\/p>\n

\nAbout Ridgemont Equity Partners
\n
<\/b>Ridgemont Equity Partners is a Charlotte-based middle market private equity firm that has provided buyout and growth capital to industry-leading companies in the business services, industrials, and healthcare sectors for three decades. The principals of Ridgemont have demonstrated an industry-focused model designed to build distinctive middle market companies. More information about Ridgemont can be found at www.ridgemontep.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
TA | Maggie Benoit | mbenoit@ta.com<\/a><\/p>\n

HealthMark Group | Ann Barty | abaty@healthmark-group.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DALLAS–(BUSINESS WIRE)–HealthMark Group (\u201cHealthMark\u201d or \u201cthe Company\u201d), a leading provider of clinical information exchange solutions for healthcare providers, today announced a strategic growth investment from TA Associates (\u201cTA\u201d), a leading global private equity firm. This partnership aims to accelerate HealthMark\u2019s growth as the Company advances its mission to optimize the exchange of healthcare data through … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61648","6":"format-standard","7":"category-industry"},"yoast_head":"\nTA Invests in HealthMark Group to Support the Next Phase of Growth - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TA Invests in HealthMark Group to Support the Next Phase of Growth - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DALLAS–(BUSINESS WIRE)–HealthMark Group (\u201cHealthMark\u201d or \u201cthe Company\u201d), a leading provider of clinical information exchange solutions for healthcare providers, today announced a strategic growth investment from TA Associates (\u201cTA\u201d), a leading global private equity firm. This partnership aims to accelerate HealthMark\u2019s growth as the Company advances its mission to optimize the exchange of healthcare data through ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-28T14:03:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250728633217\/en\/2534549\/22\/HMG_logo_wide_1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"TA Invests in HealthMark Group to Support the Next Phase of Growth\",\"datePublished\":\"2025-07-28T14:03:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/\"},\"wordCount\":785,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250728633217\\\/en\\\/2534549\\\/22\\\/HMG_logo_wide_1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/\",\"name\":\"TA Invests in HealthMark Group to Support the Next Phase of Growth - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250728633217\\\/en\\\/2534549\\\/22\\\/HMG_logo_wide_1.jpg\",\"datePublished\":\"2025-07-28T14:03:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250728633217\\\/en\\\/2534549\\\/22\\\/HMG_logo_wide_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250728633217\\\/en\\\/2534549\\\/22\\\/HMG_logo_wide_1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TA Invests in HealthMark Group to Support the Next Phase of Growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TA Invests in HealthMark Group to Support the Next Phase of Growth - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/","og_locale":"en_US","og_type":"article","og_title":"TA Invests in HealthMark Group to Support the Next Phase of Growth - Pharma Trend","og_description":"DALLAS–(BUSINESS WIRE)–HealthMark Group (\u201cHealthMark\u201d or \u201cthe Company\u201d), a leading provider of clinical information exchange solutions for healthcare providers, today announced a strategic growth investment from TA Associates (\u201cTA\u201d), a leading global private equity firm. This partnership aims to accelerate HealthMark\u2019s growth as the Company advances its mission to optimize the exchange of healthcare data through ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/","og_site_name":"Pharma Trend","article_published_time":"2025-07-28T14:03:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250728633217\/en\/2534549\/22\/HMG_logo_wide_1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"TA Invests in HealthMark Group to Support the Next Phase of Growth","datePublished":"2025-07-28T14:03:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/"},"wordCount":785,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250728633217\/en\/2534549\/22\/HMG_logo_wide_1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/","url":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/","name":"TA Invests in HealthMark Group to Support the Next Phase of Growth - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250728633217\/en\/2534549\/22\/HMG_logo_wide_1.jpg","datePublished":"2025-07-28T14:03:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250728633217\/en\/2534549\/22\/HMG_logo_wide_1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250728633217\/en\/2534549\/22\/HMG_logo_wide_1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ta-invests-in-healthmark-group-to-support-the-next-phase-of-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"TA Invests in HealthMark Group to Support the Next Phase of Growth"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61648"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61648\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}